Rapt Therapeutics ( RAPT) skyrocketed
in a massive technical breakout today, rising over 17 % to close at $36.75
RAPT, from South San Francisco, Ca is on the cutting edge of cancer research in the 21'st century,
and is working on clinical trials for two of it's patented drugs,currently seeking FDA Initial Phase 1 Approval.
I have written about Rapt Therapeutics previously in 2019,
The stock is up over 300%, since it's initial public offering at $12.00 on Oct.31,2019
For the record, I have owned, and have been accumulating
this stock strongly since it's IPO, and would recommend purchase on any pullback.
You may not believe this.
I have an upside target for RAPT,of $1000.00 a share, within the next 5 years.
RAPT Last 36.75
THE_UNWIND
1/15/20
NEW YORK
in a massive technical breakout today, rising over 17 % to close at $36.75
RAPT, from South San Francisco, Ca is on the cutting edge of cancer research in the 21'st century,
and is working on clinical trials for two of it's patented drugs,currently seeking FDA Initial Phase 1 Approval.
I have written about Rapt Therapeutics previously in 2019,
The stock is up over 300%, since it's initial public offering at $12.00 on Oct.31,2019
For the record, I have owned, and have been accumulating
this stock strongly since it's IPO, and would recommend purchase on any pullback.
You may not believe this.
I have an upside target for RAPT,of $1000.00 a share, within the next 5 years.
RAPT Last 36.75
THE_UNWIND
1/15/20
NEW YORK
Uwaga
1/17/20RAPT Closed at $46.96 on 1/16/20
Up another 28%... or $10.21
Strong Buy ! Support Now at $40.00 a share
Remember do your own due diligence.
This is not trading advise of any kind.Thank you.
THE_UNWIND
NEW YORK
Wyłączenie odpowiedzialności
Informacje i publikacje nie stanowią i nie powinny być traktowane jako porady finansowe, inwestycyjne, tradingowe ani jakiekolwiek inne rekomendacje dostarczane lub zatwierdzone przez TradingView. Więcej informacji znajduje się w Warunkach użytkowania.
Wyłączenie odpowiedzialności
Informacje i publikacje nie stanowią i nie powinny być traktowane jako porady finansowe, inwestycyjne, tradingowe ani jakiekolwiek inne rekomendacje dostarczane lub zatwierdzone przez TradingView. Więcej informacji znajduje się w Warunkach użytkowania.